當(dāng)前位置：   首頁(yè) > 需求大廳

求購(gòu)Tetrahydro-2-furancarboxylic acid《USP36-NF31》的藥典標(biāo)準(zhǔn)一份   [更多]

1、20L規(guī)模水平；2、成本在8k以下；3、雜質(zhì)符合USP標(biāo)準(zhǔn)；   [更多]

1.文章名稱： （1）A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia. Scharf, Martin B.; Roth, Thomas; Vogel, Gerald W.; Walsh, James K.The Journal of Clinical Psychiatry, Vol 55(5), May 1994, 192-199. （2）Daytime consequences and correlates of insomnia in the United States: Results of the 1991 National Sleep Foundation Survey. II. Sleep: Journal of Sleep Research & Sleep Medicine, Vol 22(Suppl 2), May 1999, S354-S358. 2.需要下載到文獻(xiàn)全文的PDF版本，以文獻(xiàn)原始名稱命名。 3.按照合格交稿的順序，先到先得，一篇文章可以獲得25元獎(jiǎng)勵(lì)   [更多]

內(nèi)容： 1、Crump M, et al. A Phase III Study of Enzastaurin in Patients with High-Risk Diffuse Large B Cell Lymphoma Following Response to Primary Treatment: The Prelude Trial. Blood 2013; 122:371 2、Prevalence of mucosal lesions in the stomach and duodenum due to chronic use of NSAID in patients with rheumatoid arthritis or osteoarthritis, and interim report on prevention by misoprostol of diclofenac associated lesions. J Rheumatol Suppl. 1991 Mar;28:11-4. 要求：上傳符合內(nèi)容的PDF格式，先到先得   [更多]

求玻璃酸鈉滴眼液注冊(cè)標(biāo)準(zhǔn)   [更多]

FDA如今每月更新一次橙皮書數(shù)據(jù)包，以前每季度更新一次，我需要FDA提供的歷史數(shù)據(jù)包，2014年，2013年，2012年，2011年，2010年乃至更早的數(shù)據(jù)包。如有保留歷史數(shù)據(jù)者，請(qǐng)與我聯(lián)系   [更多]

求吡蟲啉莫昔克丁滴劑信息 詳細(xì)要求： 需求名稱：吡蟲啉莫昔克丁信息 要求時(shí)間：請(qǐng)?jiān)?019年9月30 交稿方式：直接點(diǎn)擊交稿在線交稿就是了，我會(huì)每天過(guò)來(lái)看的，謝謝各位藥智的戰(zhàn)友們   [更多]

現(xiàn)有若干篇重要文獻(xiàn)需要下載，有CA可用帳號(hào)者應(yīng)該能接本任務(wù)。請(qǐng)與我聯(lián)系。   [更多]

2015年至2018年CFDA臨床試驗(yàn)信息（包括新藥、BE、醫(yī)療器械等）   [更多]

1.文章名稱： (1).Efficacy and safety of bazedoxifene for postmenopausal osteoporosis. Kawate H, Takayanagi R.Clin Interv Aging. 2011;6:151-60. Epub 2011 Jun 21. Review. (2).J Vasc Surg. 2017 May 19. pii: S0741-5214(17)30915-1. Medical management of claudication. Ratchford EV. (3). Neuropsychiatr Dis Treat. 2017 May 11;13:1281-1302. Comparative efficacy and safety of antipsychotics in the treatment of schizophrenia: a network meta-analysis in a Japanese population. Kishi T, Ikuta T, Matsunaga S, Matsuda Y1,, Oya K, Iwata N. (4). BMJ Case Rep. 2017 May 9;2017. pii: bcr-2017-219929. Aripiprazole-induced hypersensitivity pneumonitis. Gunasekaran K, Murthi S, Jennings J, Lone N. (5). Curr Neuropharmacol. 2017 Apr 13. Aripiprazole, a Drug that Displays Partial Agonism and Functional Selectivity. Tuplin EW1, Holahan MR. (6). Expert Opin Pharmacother. 2017 Feb;18(2):217-223. Brexpiprazole for the treatment of schizophrenia. Hsu WY, Lane HY, Lin CH. (7). J Clin Psychiatry. 2015 Sep;76(9):1232-40. Adjunctive brexpiprazole 1 and 3 mg for patients with major depressive disorder following inadequate response to antidepressants: a phase 3, randomized, double-blind study. Thase ME1, Youakim JM, Skuban A, Hobart M, Zhang P, McQuade RD, Nyilas M, Carson WH, Sanchez R, Eriksson H. (8). Ter Arkh. 2017;89(4):101-109. New opportunities for the prevention of gastric cancer. Maev IG, Kazyulin AN. (9). Oral Dis. 2017 May;23(4):511-517. Rebamipide, an anti-ulcerative drug, inhibits induction of salivary dysfunction by benzodiazepines. Ogane M, Okubo M, Yoshikawa M, Shinomiya T, Tsukagoshi E, Kawaguchi M. (10).、Int J Clin Pharm. 2017 May 29.Limited sampling strategy for predicting busulfan exposure in hematopoietic stem cell transplantation recipients.Huang JJ, Chen B, Hu J. 2.需要下載到文獻(xiàn)全文的PDF版本，以文獻(xiàn)原始名稱命名。 3.按照合格交稿的順序，先到先得，一篇文章可以獲得25元獎(jiǎng)勵(lì)   [更多]